Distinct Concentration-Dependent Molecular Pathways Regulate Bone Cell Responses to Cobalt and Chromium Exposure from...

Area of Science:

• Biomaterials Science
• Toxicology
• Cell Biology

Background:

• Elevated systemic cobalt (Co) and chromium (Cr) concentrations are observed in patients with metal joint replacement prostheses.
• Previous in vitro studies suggest detrimental effects of metal exposure on bone cells, but mechanisms are not fully understood.
• Understanding these mechanisms is crucial for addressing adverse reactions to metal debris from joint implants.

Purpose of the Study:

• To comprehensively assess gene expression in human osteoblasts and osteoclasts exposed to Co/Cr ions and nanoparticles.
• To investigate the effects of systemic versus local periprosthetic metal concentrations on bone cell function.
• To identify molecular markers for early detection of metal toxicity and understand the impact of implant surface coatings.

Main Methods:

• Whole-genome microarrays were used to analyze gene expression in primary human osteoblasts, osteoclast precursors, and mature osteoclasts.
• Cells were exposed to clinically relevant concentrations of Co²⁺, Cr³⁺ ions, and CoCr nanoparticles.
• Gene expression was also assessed in osteoblasts on different prosthesis surfaces under metal exposure conditions.

Main Results:

• Systemic metal exposure did not affect osteoblasts but inhibited osteoclast differentiation and function via focal adhesion pathways.
• Periprosthetic metal exposure inhibited both osteoblast and osteoclast activity, affecting HIF-1α signaling, cytoskeletal genes, and increasing inflammation.
• Specific gene clusters and KEGG pathways correlated with Co²⁺:Cr³⁺ ratios, serving as potential early toxicity markers.

Conclusions:

• Periprosthetic metal exposure poses a greater risk to bone cells than systemic exposure, impacting both osteoblast and osteoclast functions.
• Gene expression analysis provides mechanistic insights into adverse reactions to metal debris and identifies potential biomarkers for toxicity.
• Hydroxyapatite-coated prostheses demonstrate a pro-survival gene signature, suggesting improved clinical outcomes compared to other surface treatments.